Search

everythinglearnresearchcommunity

for

Search:↓

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Certain scalp patterns can indicate the severity and activity of hair loss in Turkish alopecia patients.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

Tofacitinib and oral minoxidil together effectively regrow hair in severe alopecia areata patients.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

The study concluded that yellow dots are a common and useful sign for diagnosing alopecia areata in dark-skinned individuals and may indicate the severity of the condition.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

A young woman with a rare hair loss condition improved with steroid and biotin treatment.

Topical tacrolimus did not regrow hair in alopecia universalis patients.

Non-immune factors play a significant role in alopecia areata.

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

Combining light therapy, acid, and microneedling improves hair regrowth in stubborn hair loss cases.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.